Trial Profile
Expanded Access to Everolimus, for an Individual Patient With Uterine Sarcoma (CTMS#18-0020)
Status:
Recruiting
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 15 Feb 2019
Price :
$35
*
At a glance
- Drugs Everolimus (Primary)
- Indications Sarcoma; Uterine cancer
- Focus Expanded access; Therapeutic Use
- 12 Apr 2018 New trial record